Global Drug Delivery Partnering Report 2010-2017: Deal Trends, Key Players and Financial Analysis - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Drug Delivery Partnering 2010-2017: Deal trends, players and financials" report to their offering.

Global Drug Delivery Partnering 2010 to 2017 provides the full collection of Drug Delivery disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Drug Delivery disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Drug Delivery deals.

Global Drug Delivery Partnering 2010 to 2017 includes:

  • Trends in Drug Delivery dealmaking in the biopharma industry since 2010
  • Analysis of Drug Delivery deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Drug Delivery deal contract documents
  • Comprehensive access to over 3500 Drug Delivery deal records
  • The leading Drug Delivery deals by value since 2010
  • Most active Drug Delivery dealmakers since 2010

In Global Drug Delivery Partnering 2010 to 2017, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in Drug Delivery dealmaking

Chapter 3 -Financial deal terms for Drug Delivery partnering

Chapter 4 - Leading Drug Delivery deals and dealmakers

Chapter 5 - Drug Delivery contract document directory

Chapter 6 - Drug Delivery dealmaking by therapeutic target

For more information about this report visit http://www.researchandmarkets.com/research/gjqhcn/global_drug

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery